| Financial Year |
March 31 2023 |
| Monetary Funds |
487,896,996.45 |
| Held-for-trading Financial Assets |
129,930,155.77 |
| Notes Receivable |
-- |
| Accounts Receivable |
408,726,371.30 |
| Advances to Suppliers |
27,892,129.13 |
| Other Receivables |
21,360,523.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
439,343,952.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
110,275,349.56 |
| Other Current Assets |
23,221,113.52 |
| Total Current Assets |
1,689,790,373.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,321,970,833.86 |
| Under-construction Projects |
167,775,758.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
457,363,152.21 |
| R&D expenses |
38,674,872.28 |
| Goodwill |
522,676,300.88 |
| Long-Term Deferred and Prepaid Expenses |
63,527,231.10 |
| Deferred Income Tax Assets |
17,654,472.26 |
| Other Non-Current Assets |
45,932,557.09 |
| Sub-Total of Non-Current Assets |
2,979,389,823.17 |
| Total Assets |
4,669,180,197.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
301,610,123.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,869,521.28 |
| Taxes Payable |
15,597,739.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
68,317,662.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,739,674.26 |
| Other Current Liabilities |
3,625,346.90 |
| Sub-Total of Current Liabilities |
507,868,135.99 |
| Long-term Loans |
-- |
| Bonds Payable |
923,481,750.71 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,061,510.00 |
| Deferred Income Tax Liabilities |
27,486,710.06 |
| Other Non-Current Liabilities |
9,843.12 |
| Sub-Total of Non-Current Liabilities |
1,310,870,618.92 |
| Total Liabilities |
1,818,738,754.91 |
| Paid-In Capital(Or Share Stock) |
180,497,320.00 |
| Capital Surplus |
1,047,574,133.61 |
| Surplus Reserve |
71,081,719.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,290,841,430.88 |
| Minority Stockholder's Interest |
194,950,284.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,655,491,157.30 |
| Owner's Equity（Stockholder's Equity） |
2,850,441,442.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,669,180,197.02 |
